ISSUE No. 4 – Aug 21, 2024

💰Iovance Biotherapeutics Secures $200M in 2024 and First FDA-Approved TIL Therapy Product | ✨ 5 Years, 15 Lessons: What I Learned Scaling and Downsizing a Startup 🚀📉

✨ 5 Years, 15 Lessons: What I Learned Scaling and Downsizing a Startup 🚀📉

My company is 5 years old. We grew from 0 to a team of 11, then downsized to 5. Here are 15 lessons I’ve learned along the way.

ISSUE No. 3 – Aug 14, 2024

💰 MIT-Spinout Kano Therapeutics raised $7.15 million in seed | ⚛️ What is the molar mass of LinkedIn?

What is the molar mass of LinkedIn?

And, why don’t we have a Nobel Prize in Marketing?

ISSUE No. 2 – Aug 7, 2024

💰 AbbVie's $8.7 Billion Acquisition of Cerevel Therapeutics | 📉 Will the Sahm’s Rule work the 10th time and predict recession? | ☝️✌️🤘 Rank money, time, and health

☝️✌️🤘 Rank money, time, and health

Let’s talk about exit strategy for Biotech.

Particularly, an overlooked exit strategy - IPO at HKEX.

ISSUE No. 1 – Jul 31, 2024

Concerto Biosciences got FDA IND approval | 🙅‍♀️ Why I never recommend entrepreneurship to anyone

The Beginning of Infinity

The very first newsletter of this newsletter, The Infinity of Biotech